Merck's approach for MoonLake ahead of late-stage clinical data for its flagship drug puts the biotech on a strong ... Illustration shows Merck logo ... NVDA NVIDIA Corporation 143.85-1.63 (-1.12%) ...

MoonLake's shares rose 19% in extended trading. Merck submitted a nonbinding offer for MoonLake earlier this year, according to the report, which added that the initial approach was rejected but talks ...

The Financial Times reports Merck submitted a nonbinding offer that valued MoonLake at more than $3 billion earlier this year. The offer was rejected, but talks could be revived, the FT said.

According to a comprehensive market research report titled "Slide Stainers Market by Product (Reagents & Kits [Stains, ...

Merck's monoclonal antibody, called clesrovimab and branded as Enflonsia, is the first and only preventive shot that can be administered as a single dose regardless of birth weight in healthy pre-term ...

EWING, N.J., June 04, 2025--Universal Display Corporation to hold virtual 2025 Annual Meeting of Shareholders on June 18, 2025 at 10:00 AM ET.

Reply of petitioner Merck Sharp & Dohme Corporation filed. (Distributed) 05/27/2025: DISTRIBUTED for Conference of 6/12/2025. 06/16/2025: Petition DENIED. Recent Posts View All. Supreme Court adds two ...

So far, the corporation has installed 2,38,167 water meters. Work is underway to install the remaining 48,041 meters by the end of the year. Apart from AMRUT scheme, there are 27,000 connections ...

Read about Merck & Co Inc (MRK:XNYS) stock and today's latest news and financial updates. MRK - Merck & Co Inc News | Morningstar Morningstar brands and products ...